Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 5, 1996, Pages 1005-1012

  Garden, Adam S ^a,b   Lippman, Scott M ^a   Morrison, William H ^a   Glisson, Bonnie S ^a   Ang, K Kian ^a   Geara, Fady ^a   Hong, Waun K ^a   Peters, Lester J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Concomitant boost; Induction chemotherapy; Nasopharyngeal carcinoma; Radiation therapy

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030471349     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00385-9     Document Type: Article

References (29)

1. 1. Al-Sarraf, M.; Leblanc, M.; Giri, P. G. S.; Fu, K.; Cooper, T.; Vuong, T.; Forastiere, A.; Adams, G.; Sakr, W.; Schuller, D.; Ensley, J. Superiority of chemo-radiotherapy vs. radiotherapy in patients with locally advanced nasopharyngeal cancer. Preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. Proc. ASCO 15:313; 1996.
2. 2. Al-Sarraf, M.; Pajak, T.; Cooper, J.; Mohiuddin, M.; Herskovic, A.; Ager, P. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: A Radiation Therapy Oncology Group study. J. Clin. Oncol. 8:1342-1351; 1990.
3. 3. American Joint Commision of Cancer. In: Beahrs, O., Henson, D., Mutter, R., and Kennedy, B., eds. Manual for staging of cancer. Philadelphia: J. B. Lippincott; 1992:33-35.
4. 4. Ang, K. K.; Peters, L. J.; Weber, R. S.; Maor, M. H.; Morrison, W. H.; Wendt, C. D.; Brown, B. W. Concomitant radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 19:1339-1345; 1990.
5. 5. Bachouchi, M.; Cvitkovic, E.; Azli, N.; Gasmi, J.; Cortes-Funes, H.; Boussen, H.; Rahal, M.; Kalifa, C.; Schwaab, G.; Eschwege, F.; Wibault, P.; Armand, J. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J. Natl. Cancer Inst. 82:616-620; 1990.
6. 6. Chan, A. T. C.; Teo, P. M. L.; Leung, T. W. T.; Leung, S. F.; Lee, W. Y.; Yeo, W.; Choi, P. H. K.; Johnson, P. J. A prospective randomized trial of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 33:569-579; 1995.
7. 7. Clark, J.; Fallon, B.; Chaffey, J.; Norris, C., Jr.; Balough, J.; Andersen, J.; Dreyfuss, A.; Anderson, R., Jr.; Miller, D. Nasopharyngeal carcinoma: The Dana-Farber Cancer Institute Experience with 24 patients treated with induction chemotherapy and radiotherapy. Ann. Otol. Rhinol. Laryngol. 96:608-613; 1987.
8. 8. Coldman, A. J.; Elwood, J. M. Examining survival data. Can. Med. Assoc. J. 121:1065-1071; 1979.
9. 9. Cox, D. R. Regression models and life tables (with discussion). J. R. Stat. Soc. 34:187-220; 1972.
10. 10. Cvitkovic, E. Neoadjuvant chemotherapy (NACT) with epirubicin (EPI), cisplatin (CDDP), bleomycin (BLEO) (BEC) in undifferentiated nasopharyngeal cancer (UCNT): Preliminary results of an international (Int) phase (PH) III trial. Proc. ASCO 13:283; 1994.
11. 11. Dimery, I.; Peters, L.; Goepfert, H.; Morrison, W.; Byers, C; Guillory, C.; McCarthy, K.; Weber, R.; Hong, W. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J. Clin. Oncol. 11:1919-1928; 1993.
12. 12. Fletcher, G. H.; Million, R. R. Nasopharynx. In: Fletcher, G. H., ed. Textbook of radiotherapy. Philadelphia, PA: Lea & Febiger; 1980:364-383.
13. 13. Fountzilas, G.; Daniilidis, P.; Kosmidis, K.; Sridhar, A.; Kalogera-Fountzila, A.; Nicolaou, A.; Makrantonakis, K.; Banis, K.; Dimitriadis, A.; Sombolos, K.; Zaramboukas, T.; Themelis, C.; Vritsios, A.; Tourkantonis, A. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. Acta Oncol. 30:831-834; 1991.
14. 14. Glisson, B. S.; Garden, A. S.; Lippman, S. M.; Geara, F.; Callender, D. L.; Goepfert, H.; Hong, W. K.; Shin, D. M.; Morrison, W. H.; Peters, L. J.; Ang, K. K. Phase I trial of conventially fractionated high dose radiation with concomitant boost chemotherapy for advanced squamous cell carcinoma of the head and neck (HNSCC). Proc. ASCO 15:312; 1996.
15. 15. Gwozdz, J. T.; Morrison, W. H.; Garden, A. S.; Ang, K. K.; Peters, L. J. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int. J. Radiat. Oncol. Biol. Phys. 32(Suppl. 1):161; 1995.
16. 16. Ho, J. H. C. Stage classification of nasopharyngeal carcinoma: A review. IACR Sci. Publ. 20:99-113; 1978.
17. 17. Kaplan, E. L.; Meier, P. A nonparametric estimation from incomplete observations. J. Am. Statis. Assoc. 53:457-481; 1958.
18. 18. Mak, A. C.; Morrison, W. H.; Garden, A. S.; Ang, K. K.; Goepfert, H.; Peters, L. J. Base-of-tongue carcinoma: Treatment results using concomitant boost radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33:289-296; 1995.
19. 19. Mantel, N.; Haenkel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:719-748; 1959.
20. 20. Mesic, J.; Fletcher, G.; Goepfert, H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 7:447-453; 1981.
21. 21. Michai, A.; Kraiphibul, P.; Clongsusuek, P.; Pochanugool, L.; Kulapaditharom, B.; Ratanatharathorn, V. Nasopharyngeal carcinoma: Result of treatment with CIS-Diamminedichloroplatinum II, 5 fluorouracil, and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:461-469; 1988.
22. 22. Neel, H. B.; Taylor, W. F. New staging system for nasopharyngeal carcinoma. Arch. Otolaryngol. Head Neck Surg. 115:1293-1303; 1989.
23. 23. Peters, L. J.; Harrison, M. L.; Dimery, I. W.; Fields, R.; Goepfert, H.; Oswald, M. J. Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 14:623-633; 1988.
24. 24. Souhami, L.; Babinowits, M. Combined treatment in carcinoma of the nasopharynx. Laryngoscope 98:881-883; 1988.
25. 25. Tannock, I.; Payne, D.; Cummings, B.; Hewitt, K.; Panzarella, T. Sequential chemotherapy and radiation for nasopharyngeal cancer: Absence of long-term benefit despite a high rate of tumor response to chemotherapy. J. Clin. Oncol. 5:629-634; 1987.
26. 26. Turner, S.; Tiver, K. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 27:371-377; 1993.
27. 27. Vikram, B.; Mishra, U. B.; Strong, E. W.; Manolatos, S. Patterns of failure in carcinoma of the nasopharynx: Failure at distant sites. Head Neck Surg. 8:276-279; 1986.
28. 28. Yokes, E. E.; Weichselbaum, R. R.; Lippman, S. M.; Hong, W. K. Head and neck cancer. N. Engl. J. Med. 328:184-194; 1993.
29. 29. Withers, H.; Taylor, J.; Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.